Ascendis Pharma Payables and Accrued Expenses (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

241.38 +2.16 (+0.90%) USD | NASDAQ | Mar 04, 16:00

241.32 -0.06 (-0.02%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	Upgrade
Evaxion AS	--
DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade